Navigation Links
GenVault Corporation to Present at the 2009 BIOCOM Investor Conference
Date:10/24/2009

CARLSBAD, Calif., Oct. 23 /PRNewswire/ -- GenVault Corporation, the leader in ambient temperature biosample management for genomic discovery, medicine and identification, today announced that David Wellis, Ph.D., GenVault's President and CEO, will be presenting at the BIOCOM Investor Conference taking place on October 26th and 27th in La Jolla, CA.

During the presentation, Dr. Wellis will provide an overview of the company together with recent customer, technical and strategic developments that have enabled GenVault to target the broader life sciences transport and storage markets. The major advantages of GenVault's technologies are the reduction of cost, waste and complexity associated with traditional biosample management in the academic and commercial sectors of the life sciences marketplace.

The following are specific details of GenVault's presentation at the conference:

BIOCOM Investor Conference

Date: Monday, October 26th, 2009

Time: 4:00pm (Track 2)

Location: Hyatt Regency La Jolla

Room: Aventine Ballroom, Room B

About GenVault

GenVault is the global leader in providing risk free biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable, reliable and environmentally friendly alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of biosamples at ambient temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlates to the Dynamic Archive, GenVault is continuously developing and refining best practices biosample management and preservation. For more information visit GenVault at www.genvault.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Bret Dash

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87941

    BUSINESS CONTACT:
    Bret Dash
    Director of Marketing
    (760) 717-3774
    bdash@genvault.com

SOURCE GenVault Corporation


'/>"/>
SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Harris Corporation Adds Broadband Satellite Data Mode to JTRS-Approved Falcon III(R) AN/PRC-117G Multiband Manpack Radio
2. M2SYS Biometric Software Solution Selected By GHG Corporation
3. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
4. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
5. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
6. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
7. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
8. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
9. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
10. Carbon Disclosure Project: Worlds largest corporations seek clarity on climate change regulation
11. L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... , March 22, 2017  UBM and ... to announce their extended partnership and the third ... headlined by the 21 st Annual MassMEDIC ... taking place May 3-4, 2017. ... Technology Association (ADVAMED) President and CEO, Scott ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com ... ... cancer conditions are being pressured as of late due to ... cancer pain management has a dramatic impact on patient,s quality ... and development activities for identifying new forms of opioid formulations ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL ... live events series, “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help “no-option” ...
Breaking Biology Technology: